You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table HSR-3. Estimated number of clients in methadone treatment and of all clients receiving any opioid substitution treatment (OST)
Part (iii) Methodological notes EU, Croatia, Turkey and Norway, 2003–11
| Country | Notes | |||
|---|---|---|---|---|
| Belgium | Estimate for 2003 based on client numbers in 2001/2002 and 2005 (mean). From 2005 onwards, data from substitution register are available. Foreign clients treated in Belgium (mainly French) not included. | |||
| Bulgaria | ||||
| Czech Republic | For 2005, data from psychiatric outpatient units were not available. Data for 2005 are an estimate, based on the most recent data available from such units. Data for 2007 include clients treated at specialised substitution centres and an estimate of the total number of buprenorphine clients. | |||
| Denmark | 2003-2005: Data refer to clients in long-term (> 5 months) methadone treatment and do not include clients treated in prisons. 2007 data: 2004 estimates, personal communication, K Grasaasen, NFP Denmark, 24 February 2009 | |||
| Germany | Census data 1 July (national substitution register), double-counting is not totally excluded. Methadone clients for 2001 are estimate that predates the introduction of the substitution register and is not comparable to other years. | |||
| Estonia | Estimated number of individual clients in methadone substitution treatment based on data collected through routine reporting from 6 treatment centres funded through NIHD. | |||
| Ireland | Data on methadone treatment clients in prison not included. All data is based on the Central Treatment List held by the Drug Treatment Centre Board on behalf of the HSE and on the National Drug Treatment Reporting System (NDTRS). This calculation attempts to exclude detoxifications. | |||
| Greece | Focal Point Data collection based on TUF questionnaire. | |||
| Spain | Data do not include substitution treatment provided to drug users in prisons (around 20.000 treatments per year). Methadone clients data up to 2003 provided by the Government Delegation for the National Plan on Drugs, with data from all Spanish Autonomous Communities | |||
| France | OFDT estimations, based on data survey on substitute prescribing performed by the Institut de Veille Sanitaire and on social security reimbursement statistics for substitution medications; personal communication, T. Canarelli, 12 March 2007 | |||
| Italy | 2003: based on data from 520 out of 562 SerT. 2005: based on national survey. 2007: estimates. | |||
| Cyprus | In Cyprus, in 2011 there were 102 clients with a primary opioid problem who received pharmacologically-assisted detoxification. | |||
| Latvia | ||||
| Lithuania | Central database on treatment covering mainly public healthcare institutions; private treatment underreported. | |||
| Luxembourg | 2005 data for Luxembourg include buprenorphine clients at GPs. | |||
| Hungary | Data collection changed from 2010 to 2011. Before 2011: double counting control at the level of treatment unit, substitution and detoxification cases reported together; in 2011: double counting control at national level, separation of substitution from detoxification data – only substitution cases are included in this table. | |||
| Malta | 2003-2005: Only clients registered at centralised methadone dispensing unit who received prescriptions for more than 3 months. Prison, GPs not included. | |||
| Netherlands | Numbers include clients in outpatient addiction care treated with methadone and diamorphine treatments. 2007 data: estimate of methadone clients. | |||
| Austria | A distinction of cases by substance is not possible in Austria. | |||
| Poland | The number of clients is given by substitution programmes on special request of National Bureau for Drug Prevention. | |||
| Portugal | Data on methadone treatments are based on census in public treatment system (CATs) each 31 December. Clients treated under responsibility of Prison Services (345 in 2003 and 271 in 2005) not included. | |||
| Romania | ||||
| Slovenia | Data prior 2007 corresponds to number of patients receiving substitution treatment in outpatient Centers for prevention and treatment of adug addiction (CPTDAs). Substitution treatment provided to drug users in prisons not included (between 300 and 400 cases per year). Personal communication Andrej Kastelic, 15 March 2006. Data for 2007: based on registry which covers 17 of 19 treatment centres. | |||
| Slovakia | Data for 2005: Personal communication Slovakia NFP, 14 March 2007. | |||
| Finland | For 2005, estimated proportion of methadone clients among all substitution clients in Finland as reported by Partanen A, Development of Low Threshold Services, Hapkohet No. 5, 2006, pp 58-59. Ratio reported in NR 2005 p. 74. Data reported under 2007 are based on an expert estimate for 2007-2008. Personal communication Sanna Rönkä, NFP Finland, 13 March 2009. For 2008, estimated proportion of methadone and buprenorphine clients among all substitution clients in Finland as reported by Ruuth, P. & Väänänen, T. (2009). Drug-user clients in services for substance abusers in 2008.http://www.stakes.fi/tilastot/tilastotiedotteet/2009/Tr14_09.pdf [1.10.2009]. Ratio reported in NR 2009 p. 56 | |||
| Sweden | ||||
| UK- England | Opiate users in prescribing treatment during the year. Data are from the National Drug Treatment Monitoring System (NDTMS) (www.ndtms.net). Client numbers refer to UK fiscal years 1 April (of the reporting year) to 31 March following calendar year. | |||
| UK-Scotland | ||||
| UK-Northern Irel. | Data refer to fiscal years 1 April (of the reporting year) to 31 March of following calendar year. | |||
| Croatia | Clients in substitution maintenance programmes. | |||
| Turkey | ||||
| Norway | Based on annual report of treatment centres. | |||